Evidence map›Paper›PMID 31432395›Full record

ArticleJournal of physiology and biochemistry2019

miR-1 induces endothelial dysfunction in rat pulmonary arteries.

Gema Mondejar-Parreño, María Callejo, Bianca Barreira, Daniel Morales-Cano, Sergio Esquivel-Ruiz, Marco Filice, Laura Moreno, Angel Cogolludo, Francisco Perez-Vizcaino

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of physiology and biochemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Perspective and Therapeutic Potential of the Noncoding RNA-Connexin Axis.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Importance of Cx43 for Right Ventricular Function.International journal of molecular sciences · 2021
    Review
  9. Review
  10. The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Gema Mondejar-Parreño *Departament of Pharmacology and Toxicology. School of Medicine, Universidad Complutense de Madrid, 28040, Madrid, Spain.
María Callejo *Departament of Pharmacology and Toxicology. School of Medicine, Universidad Complutense de Madrid, 28040, Madrid, Spain.
Bianca BarreiraDepartament of Pharmacology and Toxicology. School of Medicine, Universidad Complutense de Madrid, 28040, Madrid, Spain.
Daniel Morales-CanoDepartament of Pharmacology and Toxicology. School of Medicine, Universidad Complutense de Madrid, 28040, Madrid, Spain.
Sergio Esquivel-RuizDepartament of Pharmacology and Toxicology. School of Medicine, Universidad Complutense de Madrid, 28040, Madrid, Spain.
Marco FiliceCiber Enfermedades Respiratorias (Ciberes), Madrid, Spain.
Laura MorenoDepartament of Pharmacology and Toxicology. School of Medicine, Universidad Complutense de Madrid, 28040, Madrid, Spain.
Angel Cogolludo *Departament of Pharmacology and Toxicology. School of Medicine, Universidad Complutense de Madrid, 28040, Madrid, Spain.
Francisco Perez-Vizcaino *Departament of Pharmacology and Toxicology. School of Medicine, Universidad Complutense de Madrid, 28040, Madrid, Spain. fperez@med.ucm.es.
Universidad Complutense de Madrid · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESHospital General Universitario Gregorio Marañón · ES

Funding

Comunidad de Madrid B2017/BMD-3727Fondo Europeo de Desarrollo Regional FEDER Fundación Contra la Hipertensión Pulmonar (Empathy)Instituto de Salud Carlos III PI15/01100Ministerio de Economía, Industria y Competitividad, Gobierno de España SAF2016-77222RMinisterio de Economía y Competitividad SAF2014-55399-R
6 · The paper itself

Abstract

Endothelial dysfunction plays a central role in the pathophysiology of pulmonary arterial hypertension (PAH). MicroRNAs (miRNAs) are small single-strand and non-coding RNAs that negatively regulate gene function by binding to the 3'-untranslated region (3'-UTR) of specific mRNAs. microRNA-1 (miR-1) is upregulated in plasma from idiopathic PAH patients and in lungs from an experimental model of PAH. However, the role of miRNA-1 on endothelial dysfunction is unknown. The aim of this study was to analyze the effects of miR-1 on endothelial function in rat pulmonary arteries (PA). Endothelial function was studied in PA from PAH or healthy animals and mounted in a wire myograph. Some PA from control animals were transfected with miR-1 or scramble miR. Superoxide anion production by miR-1 was quantified by dihydroethidium (DHE) fluorescence in rat PA smooth muscle cells (PASMC). Bioinformatic analysis identified superoxide dismutase-1 (SOD1), connexin-43 (Cx43), caveolin 2 (CAV2) and Krüppel-like factor 4 (KLF4) as potential targets of miR-1. The expression of SOD1, Cx43, CAV2, and KLF4 was determined by qRT-PCR and western blot in PASMC. PA incubated with miR-1 presented decreased endothelium-dependent relaxation to acetylcholine. We also found an increase in the production of O

Indexed as

AnimalsCells, CulturedKruppel-Like Factor 4MicroRNAsMuscle, Smooth, VascularMyocytes, Smooth MusclePulmonary Arterial HypertensionPulmonary ArteryRatsRats, WistarKlf4 protein, ratKruppel-Like Factor 4MicroRNAsMIRN1 microRNA, ratEndothelial dysfunctionmiRNA-1Posttranscriptional regulationPulmonary arterial hypertensionSuperoxide dismutase

Identifiers

PMID31432395
OpenAlexW2969831454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.